Perlecan has been identified as a potential therapeutic target for the treatment of metastatic cancer because it is a necessary molecule for tumor vessels' structural integrity and forms the major storage site of neovascularization factor FGF-2 [7,38]. This evidence concerns the gene HSPG2 and metastatic malignant neoplasm.